• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用脂质体疫苗诱导疟原虫特异性免疫应答。

Induction of Plasmodium-Specific Immune Responses Using Liposome-Based Vaccines.

机构信息

Institute for Glycomics, Griffith University, Southport, QLD, Australia.

School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia.

出版信息

Front Immunol. 2019 Feb 1;10:135. doi: 10.3389/fimmu.2019.00135. eCollection 2019.

DOI:10.3389/fimmu.2019.00135
PMID:30774635
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6367261/
Abstract

In the development of vaccines, the ability to initiate both innate and subsequent adaptive immune responses need to be considered. Live attenuated vaccines achieve this naturally, while inactivated and sub-unit vaccines generally require additional help provided through delivery systems and/or adjuvants. Liposomes present an attractive adjuvant/delivery system for antigens. Here, we review the key aspects of immunity against parasites, liposome design considerations and their current application in the development of a malaria vaccine.

摘要

在疫苗的开发中,需要考虑到能够引发先天免疫和随后的适应性免疫反应的能力。减毒活疫苗自然能实现这一点,而灭活疫苗和亚单位疫苗通常需要通过传递系统和/或佐剂提供额外的帮助。脂质体是一种有吸引力的抗原佐剂/传递系统。在这里,我们回顾了针对寄生虫的免疫的关键方面、脂质体设计的考虑因素以及它们在疟疾疫苗开发中的当前应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c139/6367261/2048e555e455/fimmu-10-00135-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c139/6367261/2048e555e455/fimmu-10-00135-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c139/6367261/2048e555e455/fimmu-10-00135-g0001.jpg

相似文献

1
Induction of Plasmodium-Specific Immune Responses Using Liposome-Based Vaccines.利用脂质体疫苗诱导疟原虫特异性免疫应答。
Front Immunol. 2019 Feb 1;10:135. doi: 10.3389/fimmu.2019.00135. eCollection 2019.
2
Development and Evaluation of a Cryopreserved Whole-Parasite Vaccine in a Rodent Model of Blood-Stage Malaria.冷冻全虫疫苗在血期疟疾病鼠模型中的研制和评估。
mBio. 2021 Oct 26;12(5):e0265721. doi: 10.1128/mBio.02657-21. Epub 2021 Oct 19.
3
Molecular vaccines for malaria.疟疾的分子疫苗
Hum Vaccin. 2010 Jan;6(1):54-77. doi: 10.4161/hv.6.1.10463. Epub 2010 Jan 29.
4
infection and drug cure for malaria vaccine development.疟疾疫苗开发的感染与药物治疗。
Expert Rev Vaccines. 2021 Feb;20(2):163-183. doi: 10.1080/14760584.2021.1874923. Epub 2021 Feb 23.
5
Harnessing immune responses against Plasmodium for rational vaccine design.利用针对疟原虫的免疫应答进行合理的疫苗设计。
Trends Parasitol. 2011 Jun;27(6):274-83. doi: 10.1016/j.pt.2011.01.002. Epub 2011 Apr 30.
6
Parasite Recognition and Signaling Mechanisms in Innate Immune Responses to Malaria.先天免疫对疟疾的寄生虫识别和信号转导机制。
Front Immunol. 2018 Dec 19;9:3006. doi: 10.3389/fimmu.2018.03006. eCollection 2018.
7
Layer-by-Layer Delivery of Multiple Antigens Using Trimethyl Chitosan Nanoparticles as a Malaria Vaccine Candidate.利用三甲基壳聚糖纳米粒作为疟疾疫苗候选物进行多层递药。
Front Immunol. 2022 Aug 17;13:900080. doi: 10.3389/fimmu.2022.900080. eCollection 2022.
8
Vaccination Strategies against Malaria: novel carrier(s) more than a tour de force.疟疾疫苗接种策略:新型载体不只是权宜之计。
J Control Release. 2012 Aug 20;162(1):242-54. doi: 10.1016/j.jconrel.2012.04.037. Epub 2012 Apr 28.
9
A semi-synthetic whole parasite vaccine designed to protect against blood stage malaria.一种旨在预防血液阶段疟疾的半合成全寄生虫疫苗。
Acta Biomater. 2016 Oct 15;44:295-303. doi: 10.1016/j.actbio.2016.08.020. Epub 2016 Aug 17.
10
Optimized Malaria-antigens delivered by immunostimulating reconstituted influenza virosomes.通过免疫刺激重组流感病毒体递送的优化疟疾抗原。
Wien Klin Wochenschr. 2006;118(19-20 Suppl 3):50-7. doi: 10.1007/s00508-006-0684-0.

引用本文的文献

1
In Vivo Evaluation of PamCys-Modified Cancer-Testis Antigens as Potential Self-Adjuvanting Cancer Vaccines.PamCys修饰的癌-睾丸抗原作为潜在自佐剂癌症疫苗的体内评价
J Pept Sci. 2025 Jun;31(6):e70022. doi: 10.1002/psc.70022.
2
Liposomal Formulations of a Polyleucine-Antigen Conjugate as Therapeutic Vaccines against Cervical Cancer.一种聚亮氨酸-抗原偶联物的脂质体制剂作为抗宫颈癌治疗性疫苗
Pharmaceutics. 2023 Feb 10;15(2):602. doi: 10.3390/pharmaceutics15020602.
3
Advances in Vaccine Development: An Overview.疫苗研发进展:概述

本文引用的文献

1
A phase I, open-label trial on the safety and immunogenicity of the adjuvanted tuberculosis subunit vaccine H1/IC31® in people living in a TB-endemic area.一项关于佐剂结核亚单位疫苗H1/IC31®在结核病流行地区人群中的安全性和免疫原性的I期开放标签试验。
Trials. 2018 Jan 10;19(1):24. doi: 10.1186/s13063-017-2354-0.
2
Follicular Helper T Cells are Essential for the Elimination of Plasmodium Infection.滤泡辅助 T 细胞对于清除疟原虫感染至关重要。
EBioMedicine. 2017 Oct;24:216-230. doi: 10.1016/j.ebiom.2017.08.030. Epub 2017 Sep 4.
3
Predicting RTS,S Vaccine-Mediated Protection from Transcriptomes in a Malaria-Challenge Clinical Trial.
Pathogens. 2023 Feb 11;12(2):300. doi: 10.3390/pathogens12020300.
4
Chemopreventive Potential of Dietary Nanonutraceuticals for Prostate Cancer: An Extensive Review.膳食纳米营养剂对前列腺癌的化学预防潜力:全面综述
Front Oncol. 2022 Jul 12;12:925379. doi: 10.3389/fonc.2022.925379. eCollection 2022.
5
Liposomes for malaria management: the evolution from 1980 to 2020.脂质体用于疟疾管理:1980 年至 2020 年的发展历程。
Malar J. 2021 Jul 27;20(1):327. doi: 10.1186/s12936-021-03858-0.
6
Transdermal Immunization of Elastic Liposome-Laden Recombinant Chimeric Fusion Protein of (MSP-Fu) Mounts Protective Immune Response.负载弹性脂质体的重组嵌合融合蛋白(MSP-Fu)的经皮免疫引发保护性免疫反应。
Nanomaterials (Basel). 2021 Feb 5;11(2):406. doi: 10.3390/nano11020406.
7
Integrating Biomaterials and Immunology to Improve Vaccines Against Infectious Diseases.将生物材料学和免疫学相结合以提高传染病疫苗的效力
ACS Biomater Sci Eng. 2020 Feb 10;6(2):759-778. doi: 10.1021/acsbiomaterials.9b01255. Epub 2020 Jan 12.
8
Progress in the Development of Subunit Vaccines against Malaria.抗疟疾亚单位疫苗的研发进展
Vaccines (Basel). 2020 Jul 10;8(3):373. doi: 10.3390/vaccines8030373.
9
Variations in killer-cell immunoglobulin-like receptor and human leukocyte antigen genes and immunity to malaria.杀伤细胞免疫球蛋白样受体和人类白细胞抗原基因的变异与疟疾免疫力
Cell Mol Immunol. 2020 Aug;17(8):799-806. doi: 10.1038/s41423-020-0482-z. Epub 2020 Jun 15.
10
A New Antimalarial Noreudesmane Sesquiterpenoid from Dobinea delavayi.一种从滇藏青荚叶中分离得到的新型抗疟降香烷倍半萜类化合物。
Nat Prod Bioprospect. 2020 Apr;10(2):101-104. doi: 10.1007/s13659-020-00234-4. Epub 2020 Feb 24.
在疟疾攻击临床试验中通过转录组预测RTS,S疫苗介导的保护作用。
Front Immunol. 2017 May 23;8:557. doi: 10.3389/fimmu.2017.00557. eCollection 2017.
4
Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine.用高免疫原性的病毒样颗粒疫苗增强对疟疾的保护性免疫。
Sci Rep. 2017 Apr 19;7:46621. doi: 10.1038/srep46621.
5
Malaria vaccine: WHO position paper, January 2016 - Recommendations.疟疾疫苗:世界卫生组织立场文件,2016 年 1 月 - 建议。
Vaccine. 2018 Jun 14;36(25):3576-3577. doi: 10.1016/j.vaccine.2016.10.047. Epub 2017 Apr 3.
6
Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection.减毒PfSPZ疫苗可诱导产生跨越毒株的T细胞,并对异源受控人体疟疾感染产生持久保护作用。
Proc Natl Acad Sci U S A. 2017 Mar 7;114(10):2711-2716. doi: 10.1073/pnas.1615324114. Epub 2017 Feb 21.
7
Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial.在马里健康的疟疾暴露成年人中通过直接静脉接种PfSPZ疫苗预防恶性疟原虫的安全性和有效性:一项随机、双盲1期试验。
Lancet Infect Dis. 2017 May;17(5):498-509. doi: 10.1016/S1473-3099(17)30104-4. Epub 2017 Feb 16.
8
Safety and immunogenicity of the novel H4:IC31 tuberculosis vaccine candidate in BCG-vaccinated adults: Two phase I dose escalation trials.新型H4:IC31结核候选疫苗在卡介苗接种成人中的安全性和免疫原性:两项I期剂量递增试验
Vaccine. 2017 Mar 14;35(12):1652-1661. doi: 10.1016/j.vaccine.2017.01.055. Epub 2017 Feb 17.
9
Sterile protection against human malaria by chemoattenuated PfSPZ vaccine.化学减毒PfSPZ疫苗对人类疟疾的无菌保护作用。
Nature. 2017 Feb 23;542(7642):445-449. doi: 10.1038/nature21060. Epub 2017 Feb 15.
10
Systems analysis of protective immune responses to RTS,S malaria vaccination in humans.人类对RTS,S疟疾疫苗接种的保护性免疫反应的系统分析。
Proc Natl Acad Sci U S A. 2017 Feb 28;114(9):2425-2430. doi: 10.1073/pnas.1621489114. Epub 2017 Feb 13.